Stock events for Healthpeak Properties, Inc. (DOC)
In the past six months, Healthpeak Properties' stock experienced notable events, including the merger with Physicians Realty Trust in March 2024, which was expected to generate synergies and broaden industry relationships. In February 2025, the company increased its quarterly dividend by 1.7% and transitioned to monthly payments in April 2025. As of July 14, 2025, the share price was $18.54, representing a decline from July 15, 2024. Healthpeak reported its first-quarter 2025 results on April 24, 2025, with revenues of $702.9 million and a net income of $50.1 million. In February 2025, Kelvin Moses and Tracy Porter were promoted to Executive Vice President positions.
Demand Seasonality affecting Healthpeak Properties, Inc.’s stock price
Information directly detailing the demand seasonality for Healthpeak Properties' products and services is not explicitly available; however, demand is likely driven more by long-term demographic trends and healthcare industry growth rather than short-term seasonal fluctuations. Key drivers include increasing life expectancy, the rising senior citizen population, growth opportunities in biopharma drug development, and the healthcare sector's historically low sensitivity to economic fluctuations, suggesting stable demand for healthcare infrastructure.
Overview of Healthpeak Properties, Inc.’s business
Healthpeak Properties, Inc. is a fully integrated real estate investment trust specializing in healthcare-related facilities across the United States, operating within the healthcare sector and REIT industry. Its portfolio focuses on healthcare discovery and delivery, encompassing Lab, Outpatient Medical, and Continuing Care Retirement Community (CCRC) properties. The Lab segment includes laboratory and office spaces leased to biotechnology, medical device, and pharmaceutical companies, as well as scientific research institutions. The Outpatient Medical segment involves owning, operating, and developing outpatient medical buildings, hospitals, and other facilities, significantly expanded by the merger with Physicians Realty Trust in March 2024. The CCRC segment comprises retirement communities offering a continuum of care, considered non-core assets that may be divested.
DOC’s Geographic footprint
Healthpeak Properties, Inc. owns, operates, and develops healthcare real estate across the United States, holding interests in 697 properties as of December 31, 2024. Its lab properties are concentrated in San Francisco, San Diego, and Boston. Following the merger with Physicians Realty Trust, the combined company's portfolio includes outpatient medical properties concentrated in high-growth markets such as Dallas, Houston, Nashville, Phoenix, and Denver. Healthpeak also has corporate offices in Denver, Colorado, California, Tennessee, Wisconsin, and Massachusetts, along with property management offices in various U.S. locations, and has recently expanded its presence in New York and Cambridge, Massachusetts.
DOC Corporate Image Assessment
Healthpeak Properties maintains a strong investment-grade balance sheet and has been strategically diversifying its portfolio, particularly with the merger with Physicians Realty Trust. The company has been recognized for its corporate responsibility efforts, releasing its 13th annual Corporate Impact Report in June 2024. Events affecting its reputation include the merger with Physicians Realty Trust, which was viewed positively for its strategic foresight, underperformance relative to the industry and market, which could negatively impact investor sentiment, and a slight downward revision of revenue expectations for FY2025, signaling a cautious outlook.
Ownership
Healthpeak Properties, Inc. is primarily owned by institutional shareholders, who hold approximately 93.98% of the company's stock, while insiders own about 1.58%, and retail investors account for 4.44%. The largest individual shareholder is Vanguard Group Inc, owning 16.06% of the company. Other major institutional owners include BlackRock, Inc., State Street Corp, and Invesco Ltd.
Ask Our Expert AI Analyst
Price Chart
$17.90
Top Shareholders
Sentiment for DOC
Loading...
Loading...
Loading...